Hypothesis/Introduction: In the neonatal period, many factors may interfere with aldosterone production but data currently available are few and controversial. In this study we aim to assess the early urinary aldosterone excretion (UAE) in very low birth weight (VLBW) infants and to identify some possible clinical and biochemical variables that may influence this excretion.
Introduction
Aldosterone is a part of the renin-angiotensin-aldosterone system (RAAS) that plays an important role in regulation of blood volume and arterial pressure and in homeostasis of serum sodium and potassium. 1 In children and adults aldosterone secretion is stimulated primarily by the angiotensin II, which is produced by renin action. Active renin secretion is regulated principally by several interdependent factors: a renal baroreceptor mechanism in the afferent arteriole that senses changes in renal perfusion pressure, changes in delivery of NaCl to the macula densa cells of the distal tubule and sympathetic nerve stimulation via beta-1 adrenergic receptors. 2 In the neonatal period many factors may interfere with aldosterone production, such as gestational age, birth weight, drugs and degree of illness. In previous reports we have shown that both acute and long-term administration of furosemide in preterm infants, to prevent or treat chronic lung disease, determines an increased urinary excretion of aldosterone. 3, 4 The aim of our study was to assess the urinary aldosterone excretion (UAE) in the first 72 hours of life in very low birth weight infants and to identify some possible clinical and biochemical variables that may influence UAE.
Materials and methods
This study was designed as a prospective observational study and was performed between March 2005 and October 2007. Written informed consent was obtained from the parents and the Ethical Committee of Department of Paediatrics approved the study.
Newborn infants less than 1500 g without major congenital malformations or chromosomal syndromes were included in the study.
During the first 72 hours of life urine was collected for 24 hours. A plastic urine collection bag was applied to the infant's perineum and urine was removed from the bag and refrigerated as soon as possible after each void. At the end of each collection a mild suprapubic pressure was applied to empty the bladder as completely as possible. Loss of urine has been evaluated weighting diapers after urine collection bag voiding. Urine collection failure has been defined as a urine loss more than 15% of overall 24 hours' diuresis. Urine collection has been stopped if an important perineal rash appeared.
All samples were stored at 4°C until analysis. Measurement of urinary aldosterone was made by radioimmunoassay manufactured by Diagnostic Products Corporation (USA), which has intra-and inter-assay coefficients of variation of 4.7% and 5.7%, respectively. The urine aldosterone was expressed in µg/24 h, indicating the overall amount of aldosterone excreted during 24 h diuresis and in pg/ml, indicating the absolute amount of aldosterone excreted. Plasma sodium, potassium and chloride were measured by flame photometry at the end of urine collection.
In each patient blood pressure was recorded six times per day and diagnosis of hypotension was made when mean blood pressure was <10° percentile, according to the reference values reported by Watkins et al., in the presence of clinical signs of hypoperfusion such as metabolic acidosis, diuresis contraction, tachycardia, prolonged capillary refill time. 5 In all infants the presence of respiratory distress syndrome (RDS), patent ductus arteriosus (PDA), intraventricular haemorrhage (IVH) and sepsis were recorded. RDS was clinically diagnosed by the need for mechanical ventilation with oxygen requirement >30% or the need for continuous positive airway pressure with oxygen requirement >40%, in the presence of radiographic chest findings (air bronchograms and reticulogranular appearance of the pulmonary parenchyma). IVH was graded according to Papile et al. 6 Sepsis was diagnosed in the presence of positive blood or cerebrospinal fluid cultures.
An exploratory analysis was conducted with the Mann-Whitney U test to assess association between UAE and dichotomous variables, and with Pearson's correlation coefficient between UAE and continuous variables.
A stepwise linear regression analysis was then conducted including in the model only the variables significant after exploratory analysis, to account for the influence of the various factors on the UAE. p-values <0.05 were considered to be statistically significant. Data were analysed using Stata/IC 11.1 for Windows.
Results
Thirty-five consecutive infants were enrolled in the study, but only 30 infants were studied because five were rejected (four because of urine collection failure, one because of perineal rash). Baseline characteristics of the study population are shown in Table 1 . None of the patients studied had hypotension.
The mean (±SD) age at which the 24 hours urine collection was performed was 44±14 hours of life. The median (interquartile range) overall UAE value was 0.20 (0.17-0.33) µg/24 h and the median (interquartile range) absolute amount of aldosterone excreted in the urine was 0.05 (0.03-0.09) pg/ml.
The exploratory analysis is presented in Tables 2 and 3 . The only categorical variable associated with urinary aldosterone was RDS ( Table 2 ). Among the continuous variables, gestational age, birth weight, plasma sodium and chloride and urinary sodium and chloride were significantly correlated to UAE ( Table 3) .
The stepwise linear regression analysis was started with all the variables associated to UAE in the initial model; the significance level for addition to the model was set to 0.2 and the significance level for removal from the model was set to 0.3. All variables except plasma sodium and gestational age were dropped in the final model. The final model showed a significant independent association between plasma sodium and UAE (coefficient -0.02, 95% confidence interval, CI [-0.03; -0.004]; adjusted R 2 0.33).
Discussion
Aldosterone, as a part of the RAAS, plays a key role in the homeostatic control of arterial pressure, tissue perfusion and extracellular volume. Aldosterone production may increase in several pathological conditions such as chronic cardiac failure or nephro-vascular hypertension. [7] [8] [9] Moreover, also the administration of loop diuretics may increase aldosterone production as a consequence of the physiological adaptation to the sodium and water wasting, secondary to the inhibition of tubular chloride transport and carbonic anhydrase activity in the proximal tubule. These diuretic actions lead to an overload of sodium and water to the distal tubules, which stimulates the RAAS. 3, 4, 10 While clear reference values for aldosterone exist for paediatric populations, few and heterogeneous data are available for term and preterm neonates. [11] [12] [13] [14] [15] [16] [17] [18] The studies carried out during the neonatal period varied in the timing of sampling and almost all determined aldosterone plasma level.
In our study we found that, in a population of very low birth weight infants, the median (interquartile range) overall UAE value during the first 72 hours of life was 0.20 (0.17-0.33) µg/24 h. We chose to measure aldosterone levels in urine to avoid blood sampling in tiny babies and, since urinary excretion of aldosterone may be affected by diuresis, we determined also the absolute median (interquartile range) amount of aldosterone excreted in the urine, which was 0.05 (0.03-0.09) pg/ml.
Recently, Martinerie and colleagues suggested that urinary aldosterone measurement is the best index for accurate evaluation of the mineralocorticoid effector mechanisms and that plasma aldosterone is not a good parameter at birth. These authors found that in a population of 48 term neonates urinary aldosterone, unlike plasma aldosterone, was significantly and negatively correlated to the plasma potassium, leading to the conclusion that aldosterone participates in the control of potassium balance and that determination of urinary aldosterone levels constitutes an interesting non-invasive method to investigate aldosterone sensitivity in preterm and full-term infants. 19 In the neonatal period, several clinical and biochemical variables, such as gestational age, birth weight, plasma electrolytes, drugs and degree of illness, may interfere with aldosterone production.
In the present study, the variables significantly associated with UAE in the exploratory analysis were RDS, gestational age, birth weight, plasma sodium and chloride and urinary sodium and chloride. Nevertheless, the only variable independently associated to the UAE in the linear regression analysis was plasma sodium. Indeed, infants with lower plasma sodium had higher UAE.
These findings are not in agreement with those of Leslie et al., who found infants with RDS to have levels of UAE similar to those of infants without RDS. 20 On the contrary, we found that infants without RDS had higher urine aldosterone levels than those with RDS, though it is not the RDS itself that affects the aldosterone excretion. The explanation of this finding may be that patients with RDS often present with an oliguric phase, followed by a spontaneous diuretic phase, typically occurring at 24-72 h, that precedes the improvement in lung disease. 21, 22 We hypothesize that, during this oliguric phase of the disease, there is an increase in extracellular volume with consequent hyponatraemia that stimulates aldosterone production.
Our data are consistent, instead, with those of Bourchier, who found a negative correlation between plasma sodium levels and plasma aldosterone at seven days of life, but not in the first day of life. 18 We found a negative correlation between plasma sodium and UAE already during the first three days of life that may confirm the physiological partial aldosterone resistance in human neonates, due to a progressive increase of renal mineralocorticoid receptor expression level in the first days after birth, concurrently with renal maturation. 23, 24 In the exploratory analysis we found a significant positive correlation between UAE and gestational age and birth weight, suggesting that UAE increases with gestational age and birth weight; however, these variable were not independently associated to the UAE in the linear regression analysis. The influence of gestational age and birth weight on aldosterone production has been controversial. In fact, Dörr et al. found a higher umbilical cord aldosterone level in premature infants than in term infants, whereas Hubl et al. showed that umbilical cord aldosterone levels increase with gestational age. 25, 26 Procianoy and Oliveira-Filho found a significant positive correlation between birth weight and serum umbilical cord aldosterone levels, while Bourchier found that plasma aldosterone levels were unaffected by gestational age. 17, 18 
Conclusions
The conclusions we can draw from the present study are that the RAAS of very low birth weight infants seems to be able, even immediately after birth, to respond to variations of plasma sodium concentrations, and that measurement of urinary aldosterone levels constitutes an interesting method to determine aldosterone production, avoiding blood sampling in neonates so small and frail as very low birth weight infants. We believe that these results have an important practical implication, since early and longitudinal monitoring of urinary aldosterone excretion may be useful in some clinical conditions that require chronic diuretic treatment, such as congestive heart failure and bronchopulmonary dysplasia.
The sample size of our study is not large enough to detect the presence of other independent variables that influence the production of aldosterone and further clinical investigations need to be conducted to evaluate aldosterone resistance and the regulation of the RAAS in preterm and full-term neonates.
